and, on top of this, the company developed a trial for this "de-risked" product with "proven potency and efficacy" that was specifically designed to screen out patients who were not likely to respond well...and all the time they hid from us the debacle about the fraudulent withdrawn QUT research papers....
Ann: Shareholder Update, page-8
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
